All Articles

Fintech innovator Pipe raises $16M in a new round, signaling strong investor confidence in its model of providing fast, embedded capital to small businesses.

The AI-powered contract platform's rapid growth highlights a legal tech revolution, as demand for intelligent automation reshapes the enterprise landscape.

With 16 top doctors and back-to-back honors, see how this practice combines elite medical care with a unique business model to lead Delaware's healthcare.

Luma is submitting 21 AI-generated films to Cannes Lions, challenging the ad world and testing the new frontier of human-machine creative collaboration.

Newcomer Prismic Life's major deal with Daiichi Life highlights a trend of Japanese insurers offloading risk to PE-backed platforms in Bermuda.

As youth pitcher injuries reach epidemic levels, a new partnership aims to change the game by delivering elite medical advice directly to coaches and parents.

With a $15M seed round, Rork's AI platform lets anyone build native mobile apps using plain English, aiming to unleash a new wave of App Store entrepreneurs.

As CMS halts new provider enrollments to fight waste, one company's new model for incontinence supplies could offer a blueprint for industry-wide reform.

China's Gan & Lee partners with JW Pharmaceutical to launch its novel bi-weekly GLP-1 drug, Bofanglutide, into the competitive South Korean market.

For seven years, IMG has sent employees to build schools in Central America. It’s a strategy that builds brand loyalty, employee purpose, and community hope.

CB&I completes its acquisition of Petrofac's asset arm, a strategic diversification move fueled by the seller's deep financial turmoil and debt crisis.

A $60M project in Union City gets the green light to bury CO2, promising economic boons and sparking debate on the future of green technology.

3Play Media's new service combines AI speed with human review and deep analytics, promising to turn the guesswork of global expansion into a data-driven strategy.

In a tough fundraising climate, Court Square's oversubscribed Fund V signals strong investor confidence in its 47-year track record and middle-market strategy.

A stable year for Canada's West Coast ports masks urgent calls for federal action to prevent future supply chain chaos ahead of critical 2027 labor talks.

Luminai's new funding highlights a major VC trend: betting on AI to solve the multi-billion dollar problem of healthcare administrative waste.

With a personal family connection to type 1 diabetes and a £100M war chest, Anastasia Bukhman joins the T1D Fund's board to speed up research.

A new non-invasive therapy using ultrasound to activate a cancer-targeting drug enters a crucial Phase 2b trial, offering new hope for glioblastoma patients.

The EV maker is executing a massive reverse stock split to stay on Nasdaq, but tanking shares and weak financials reveal a much tougher road ahead.

A $29.7M contract for Beehive Industries' Frenzy engines signals a major U.S. military shift to an 'affordable mass' arsenal powered by 3D printing.